Emanuela Silva‐Alvarenga
Papers
2
Total Citations
80
H-Index
2
About
Emanuela Silva‐Alvarenga is a leading surgical oncologist whose research focuses on optimizing treatment strategies for rectal adenocarcinoma, particularly through minimally invasive approaches. Her work has fundamentally shaped our understanding of how surgical techniques and evolving management paradigms affect patient outcomes. Her landmark 2022 study, “Trends in the Characteristics, Treatment, and Outcomes of Rectal Adenocarcinoma in the US From 2004 to 2019,” with 65 citations, provides a critical, comprehensive analysis of two decades of practice shifts, highlighting improvements in survival and the increasing adoption of neoadjuvant therapy. She is also renowned for her pioneering comparative effectiveness research, exemplified by her 2022 study on laparoscopic versus robotic-assisted resection for T4 rectal cancer (15 citations). This work, using a propensity score-matched analysis of a national cancer database, directly addresses the technical challenges of achieving R0 resection in locally advanced disease, offering crucial evidence for surgical decision-making. Silva‐Alvarenga’s contributions are vital for clinicians navigating the complex landscape of modern rectal cancer care, providing data-driven insights that directly improve surgical outcomes and patient survival.
Research Focus
Key Achievements
Top Papers
- 1
- 2